Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NIM 1324

Next Previous
Drug Profile

NIM 1324

Alternative Names: BT-104; LABP-104; NIM-1324

Latest Information Update: 14 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Landos Biopharma
  • Developer Landos Biopharma; NImmune Biopharma
  • Class Anti-inflammatories; Antirheumatics; Small molecules; Urologics
  • Mechanism of Action Inflammation mediator inhibitors; LANCL2 protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Lupus nephritis; Rheumatoid arthritis; Systemic lupus erythematosus
  • Preclinical Inflammatory bowel diseases

Most Recent Events

  • 10 Sep 2026 Preclinical trials in Inflammatory bowel diseases in USA (PO)
  • 10 Sep 2026 Pharmacodynamics data from a preclinical trial in Inflammatory bowel diseases presented at the Digestive Disease Week 2026 (DDW-2026)
  • 05 May 2026 Pharmacokinetics, pharmacodynamics and adverse events data from a phase I trial in Systemic lupus erythematosus presented at the Digestive Disease Week, 2026 (DDW-2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top